Definitive Contract 75N91018C00010
Award Date
9/17/18
Potential Completion Date
6/30/22
Potential Value
$1.7M
Federal Agency
National Cancer Institute
Awardee
Medable Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94301, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,773,570.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Medable Inc., a self-certified small disadvantaged business. The contract is for a project titled "Connecting Cancer Caregivers to Care Teams: Digital Platforms to Support Informal Cancer Caregiving" under Topic 363 from Fiscal Year 2017. The contract is a definitive contract with...
This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a "CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This definitive firm fixed price contract was awarded by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Digital Nanogenetics LLC on September 17, 2018. With a potential value of $300,000, the contract is associated with the Small Business Innovation Research Program Phase I and has a completion date of September 19, 2019. The contract has a set aside designation for total small businesses and will support research...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
This is a $299,999.00 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Electronic Biosciences, Inc., a small business. The contract is for the ALTERNATING-SEQ (MOONSHOT) requirement, which has a firm fixed price pricing structure and a completion date of March 16, 2020. Electronic Biosciences has prior experience providing goods and services such as nanopore platforms, temperature-controlled systems,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
<p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The $225,000 Firm Fixed Price contract was awarded to Dimagi Inc., a self-certified small disadvantaged business, to develop a digital health solution to support long-term cancer survivorship using patient navigation. The contract is part of the NCI Cancer Moonshot program. Dimagi...
This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Massive Bio, Inc. for $399,594. The contract is associated with the National Institutes of Health and Centers for Disease Control and Prevention SBIR Phase I solicitation seeking proposals for research and development in support of cancer-related topics including clinical trials recruitment and retention tools for participant engagement. The contract will be performed in New York, New York from...